Stay updated with breaking news from Lantern Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Patient selection using DRP score of 50% resulted in a median survival of 15.0 monthPatient selection using DRP score of 67% resulted in a median survival of 20.6 months Press Release Hørsholm
Press Release Hørsholm, Denmark – Allarity Therapeutics A/S today announces that an accelerated extraordinary and final exercise period for warrants of the ALLR TO 3 series , which... | August 27, 2021